-
Haleon Plc. (HLN) PT Lowered to $13.41 at Berenberg
-
BNP Paribas Exane Starts Haleon Plc. (HLN) at Outperform
-
Morgan Stanley considers this UK stock as 'an attractive defensive play'
-
Morgan Stanley Upgrades Haleon PLC (HLN:LN) (HLN) to Overweight
-
Morgan Stanley Upgrades Haleon Plc. (HLN) to Overweight
-
HSBC Downgrades Haleon PLC (HLN:LN) (HLN) to Hold
-
Haleon Plc. (HLN) PT Raised to $10.35 at Morgan Stanley
-
Haleon Plc. (HLN) PT Lowered to $10.05 at Morgan Stanley
-
Jefferies Reiterates Buy Rating on Haleon PLC (HLN:LN) (HLN)
-
Pfizer (PFE) Intends To Sell About 700M Haleon (HLN) Shares
-
Bernstein SocGen Group Downgrades Haleon PLC (HLN:LN) (HLN) to Market Perform
-
Haleon Plc. (HLN) PT Lowered to $10.65 at Morgan Stanley
-
Pfizer (PFE) Boosts Haleon (HLN) Offering Size To 640m Shares From 540m - Bloomberg
-
Pfizer (PFE) Intends To Sell About 540M Haleon (HLN) Shares - Bloomberg
-
Haleon PLC (HLN:LN) (HLN) PT Raised to GBP4.15 at Morgan Stanley
-
Haleon PLC (HLN:LN) (HLN) PT Raised to GBP4.40 at BofA Securities
-
Haleon (HLN) Announces the Launch of Eroxon
-
Berenberg Starts Haleon Plc. (HLN) at Buy
-
Goldman Sachs Downgrades Haleon PLC (HLN:LN) (HLN) to Neutral
-
Haleon PLC (HLN:LN) (HLN) PT Lowered to GBP3.40 at Deutsche Bank

